In order to prevent bronchospasm caused by exercise or unavoidable exposure to a known allergen, 15 minutes before the expected exposure to the allergen or until the load should be inhaled 12 mg of the drug (the contents of 1 capsule).
Patients with severe bronchospasm c history may be required for preventing inhalation contents 2 Capsule (24 mg). In tren cycle dose for regular maintenance therapy is at 12-24 g (1-2 capsules contents), 2 times a day. Children 5 years and over the maximum recommended dose is 24 mg per day. in bronchial asthma drug dose for regular maintenance therapy is 12 mg 2 times a day. The l should only be used as adjunctive therapy to inhaled corticosteroids. Children from 5 to 12 years are recommended to use combination products containing inhaled corticosteroids and beta agonist 2 -adrenoceptor long-acting, except where the need for their independent use. For the purpose of prevention of bronchospasm caused by exercise or unavoidable exposure to a known allergen, 15 minutes before the expected exposure to the allergen or until the load should be inhaled the contents of 1 capsule (12 mg). Instructions for the inhalation In order to ensure the correct use of the drug, a physician or other health care professional should show the patient how to use the inhaler; explain to the patient that use capsules with powder for inhalation should be only through Aerolayzera; warn the patient that the capsules are only for inhalation use and not intended for ingestion. Children should use the drug under the supervision of adults.
Elderly patients (over 65 years) no evidence to support the need of the drug in a different dose in patients over 65 years compared to more younger patients received. it is important that the patient realized that due to the destruction of gelatin capsules the gelatin in small pieces by inhalation can get into the mouth or throat. In order to reduce this phenomenon to a minimum, do not pierce the capsule 1 more times. To tren cycle take out the capsule from the blister pack immediately before use.(See. For instructions on the use of Aerolayzera). There are isolated reports of patients accidentally swallowed drug capsules whole. Most of these cases are not associated with the development of adverse events. The health worker should explain to the patient how to use the drug, especially if after the inhalation of the patient is not breathing comes improvement.
Adverse reactions (adverse events) are distributed according to frequency of occurrence. The following criteria are used to assess frequency: very common, including isolated reports. Violations of the immune system: very rarely – hypersensitivity reactions, such as lowering blood pressure, urticaria, angioneurotic edema, pruritus, rash. Mental Disorders: Infrequent – agitation, anxiety, irritability, insomnia. Disorders of the nervous system: often – headache, tremor; Infrequent – dizziness; very seldom – taste disturbances. Disturbances of the heart: often – palpitations; rarely – tachycardia; very rarely – peripheral edema. Violations of the respiratory system, organs, thoracic and mediastinal disorders:rarely – bronchospasm, including paradoxical.
General disorders and in the introduction: rare – irritation of the mucous membrane of the pharynx and larynx. Violations of the gastrointestinal tract: rare – dryness of the oral mucosa; very rarely – nausea. Violations of the musculoskeletal and connective tissue disorders: rarely – muscle spasm, myalgia. According to postmarketing observations in the appointment of Foradil drug note the following adverse events, the frequency of which was regarded as “frequency not known” because of the small number of patients: Laboratory and instrumental data:hypokalemia and hyperglycemia, lengthening of the tren cycle interval on the electrocardiogram, elevated blood pressure (including hypertension). Violations of the respiratory system, organs, thoracic and mediastinal disorders: coughing. Violations of the skin and subcutaneous tissue disorders: rash. from Violations heart: . angina pectoris, cardiac arrhythmias (including atrial fibrillation, ventricular extrasystoles, tachyarrhythmia) in clinical studies with the use of formoterol has been a slight increase in the frequency of severe exacerbations of asthma compared with placebo. However, the results of the above clinical studies do not allow a quantitative estimate of the incidence of severe exacerbations of asthma in different groups. If any of these instructions side effects are compounded, or if you notice any other side effects not mentioned in the instructions, inform your doctor.